Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 97,247 |
|
|||||
| News | - | ||||||
| Day High | 1.0706 | Low High |
|||||
| Day Low | 1.02 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Quince Therapeutics Inc | QNCX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.01 | -0.94% | 1.05 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.05 | 1.02 | 1.0706 | 1.05 | 1.06 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 823 | 97,247 | US$ 1.06 | US$ 102,667 | - | 0.84 - 1.74 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:06:16 | 1 | US$ 1.0201 | USD |
Quince Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 83.59M | 42.87M | - | 0 | -31.39M | -0.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Quince Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/01/2024 | 06:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
| 2/22/2024 | 06:00 | Business Wire | Quince Therapeutics Launches Scientific Advisory Board |
| 2/15/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/15/2024 | 06:00 | Business Wire | Quince Therapeutics Appoints Former Reata Pharmaceuticals.. |
| 2/07/2024 | 15:05 | Business Wire | Quince Therapeutics to Present at Oppenheimer 34th Annual.. |
| 2/02/2024 | 16:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/05/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 1/04/2024 | 15:05 | Business Wire | Quince Therapeutics to Participate at Investor Events in.. |
| 1/03/2024 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/22/2023 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/14/2023 | 17:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/08/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QNCX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.97 | 1.0706 | 0.89 | 0.9837323 | 179,907 | 0.08 | 8.25% |
| 1 Month | 1.17 | 1.25 | 0.89 | 1.02 | 85,674 | -0.12 | -10.26% |
| 3 Months | 1.30 | 1.42 | 0.89 | 1.17 | 69,354 | -0.25 | -19.23% |
| 6 Months | 1.05 | 1.4301 | 0.84 | 1.11 | 78,664 | 0.00 | 0.00% |
| 1 Year | 1.52 | 1.74 | 0.84 | 1.25 | 143,677 | -0.47 | -30.92% |
| 3 Years | 38.19 | 121.98 | 0.5401 | 11.04 | 616,939 | -37.14 | -97.25% |
| 5 Years | 20.00 | 121.98 | 0.5401 | 15.29 | 434,542 | -18.95 | -94.75% |
Quince Therapeutics Description
| Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. |
